tradingkey.logo


tradingkey.logo


Cencora Inc

COR
325.190USD
+4.580+1.43%
āļ›āļīāļ” 03/25, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
84.03BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
38.81P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Cencora Inc āļšāļĢāļīāļĐāļąāļ—

Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.

āļ‚āđ‰āļ­āļĄāļđāļĨ Cencora Inc


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™COR
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Cencora Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļMay 28, 1996
āļ‹āļĩāļ­āļĩāđ‚āļ­Mauch (Robert P)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™51000
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“May 28
āļ—āļĩāđˆāļ­āļĒāļđāđˆ1 West First Avenue
āđ€āļĄāļ·āļ­āļ‡CONSHOHOCKEN
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX NASDAQ Basic NYSE
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ19428
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ16107277000
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.cencora.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™COR
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļMay 28, 1996
āļ‹āļĩāļ­āļĩāđ‚āļ­Mauch (Robert P)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ Cencora Inc


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
30.71K
+22.08%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
23.57K
+20.12%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
17.62K
+3.16%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.17K
+4.58%
Mr. Pawan Verma
Mr. Pawan Verma
Executive Vice President, Chief Data and Information Officer
Executive Vice President, Chief Data and Information Officer
5.15K
+18.73%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
3.13K
+3.45%
Ms. Lori J. Ryerkerk
Ms. Lori J. Ryerkerk
Independent Director
Independent Director
1.07K
+51.91%
Dr. Lorence H. Kim, M.D.
Dr. Lorence H. Kim, M.D.
Independent Director
Independent Director
168.00
-469.64%
Ms. Lauren M. Tyler
Ms. Lauren M. Tyler
Independent Director
Independent Director
--
--
Mr. Franklin K. (Frank) Clyburn, Jr.
Mr. Franklin K. (Frank) Clyburn, Jr.
Independent Director
Independent Director
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
30.71K
+22.08%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
23.57K
+20.12%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
17.62K
+3.16%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.17K
+4.58%
Mr. Pawan Verma
Mr. Pawan Verma
Executive Vice President, Chief Data and Information Officer
Executive Vice President, Chief Data and Information Officer
5.15K
+18.73%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
3.13K
+3.45%

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡āļĒāļąāļ‡āđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļāļēāļĢāđ€āļ›āļīāļ”āđ€āļœāļĒāļˆāļēāļāļ—āļēāļ‡āļšāļĢāļīāļĐāļąāļ—
āļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡āļĒāļąāļ‡āđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļāļēāļĢāđ€āļ›āļīāļ”āđ€āļœāļĒāļˆāļēāļāļ—āļēāļ‡āļšāļĢāļīāļĐāļąāļ—
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡āļĒāļąāļ‡āđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļāļēāļĢāđ€āļ›āļīāļ”āđ€āļœāļĒāļˆāļēāļāļ—āļēāļ‡āļšāļĢāļīāļĐāļąāļ—

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļĻāļļāļāļĢāđŒāļ—āļĩāđˆ 20 āļ.āļž.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļĻāļļāļāļĢāđŒāļ—āļĩāđˆ 20 āļ.āļž.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
12.10%
BlackRock Institutional Trust Company, N.A.
6.60%
State Street Investment Management (US)
4.78%
Walgreens Holding Co
3.84%
T. Rowe Price Investment Management, Inc.
3.44%
āļ­āļ·āđˆāļ™ āđ†
69.23%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
12.10%
BlackRock Institutional Trust Company, N.A.
6.60%
State Street Investment Management (US)
4.78%
Walgreens Holding Co
3.84%
T. Rowe Price Investment Management, Inc.
3.44%
āļ­āļ·āđˆāļ™ āđ†
69.23%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
56.85%
Investment Advisor/Hedge Fund
28.16%
Corporation
3.84%
Research Firm
2.87%
Pension Fund
2.38%
Bank and Trust
2.28%
Hedge Fund
2.09%
Sovereign Wealth Fund
1.31%
Family Office
1.17%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 8 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 8 āļ˜.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q4
2325
185.17M
94.90%
+31.68K
2025Q3
2360
185.31M
95.09%
+4.64M
2025Q2
2343
180.65M
95.85%
-533.00K
2025Q1
2278
180.99M
94.03%
-1.15M
2024Q4
2205
177.00M
96.12%
-3.08M
2024Q3
2114
179.91M
93.30%
+3.58M
2024Q2
2070
176.04M
91.35%
-1.09M
2024Q1
2048
176.18M
88.49%
-350.13K
2023Q4
1964
171.90M
85.06%
+6.01M
2023Q3
1864
166.03M
82.05%
+4.34M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
The Vanguard Group, Inc.
23.31M
12.02%
+914.30K
+4.08%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
12.81M
6.6%
+782.50K
+6.50%
Sep 30, 2025
State Street Investment Management (US)
9.19M
4.74%
+782.91K
+9.31%
Sep 30, 2025
Walgreens Holding Co
7.47M
3.85%
-2.91M
-28.01%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
2.58M
1.33%
+1.97M
+327.39%
Sep 30, 2025
T. Rowe Price Associates, Inc.
7.35M
3.79%
-108.21K
-1.45%
Sep 30, 2025
Geode Capital Management, L.L.C.
5.29M
2.73%
+502.81K
+10.50%
Sep 30, 2025
Fidelity Management & Research Company LLC
2.95M
1.52%
+162.66K
+5.84%
Sep 30, 2025
Wellington Management Company, LLP
3.97M
2.05%
+115.28K
+2.99%
Sep 30, 2025
JP Morgan Asset Management
3.74M
1.93%
+976.86K
+35.34%
Sep 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
VanEck Pharmaceutical ETF
8.42%
AdvisorShares Focused Equity ETF
5.56%
First Trust Consumer Staples Alphadex Fund
3.52%
Goldman Sachs Future Health Care Equity ETF
3.48%
VanEck Retail ETF
3.31%
Hennessy Sustainable ETF
3.08%
iShares US Consumer Staples ETF
3.02%
American Century Mid Cap Growth Impact ETF
2.66%
SEI Enhanced US Large Cap Momentum Factor ETF
2.51%
Counterpoint Quantitative Equity ETF
2.4%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
VanEck Pharmaceutical ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™8.42%
AdvisorShares Focused Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™5.56%
First Trust Consumer Staples Alphadex Fund
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.52%
Goldman Sachs Future Health Care Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.48%
VanEck Retail ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.31%
Hennessy Sustainable ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.08%
iShares US Consumer Staples ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.02%
American Century Mid Cap Growth Impact ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.66%
SEI Enhanced US Large Cap Momentum Factor ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.51%
Counterpoint Quantitative Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.4%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 2.01B USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
Feb 04, 2026
COR.NB Interim Cash Dividend of gross USD 0.6 paid on Mar 02, 2026 going ex on Feb 13, 2026
Feb 13, 2026
Mar 02, 2026
Feb 13, 2026
Nov 04, 2025
COR.NB Final Cash Dividend of gross USD 0.6 paid on Dec 01, 2025 going ex on Nov 14, 2025
Nov 14, 2025
Dec 01, 2025
Nov 14, 2025
Aug 06, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Sep 03, 2025 going ex on Aug 15, 2025
Aug 15, 2025
Sep 03, 2025
Aug 15, 2025
May 07, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Jun 02, 2025 going ex on May 16, 2025
May 16, 2025
Jun 02, 2025
May 16, 2025
Feb 05, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Mar 03, 2025 going ex on Feb 14, 2025
Feb 14, 2025
Mar 03, 2025
Feb 14, 2025
Nov 06, 2024
COR.NB Final Cash Dividend of gross USD 0.55 paid on Nov 29, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Nov 29, 2024
Nov 15, 2024
Jul 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 26, 2024 going ex on Aug 09, 2024
Aug 09, 2024
Aug 26, 2024
Aug 09, 2024
May 01, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on May 24, 2024 going ex on May 09, 2024
May 10, 2024
May 24, 2024
May 09, 2024
Jan 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 26, 2024 going ex on Feb 08, 2024
Feb 09, 2024
Feb 26, 2024
Feb 08, 2024
Nov 02, 2023
COR.NB Final Cash Dividend of gross USD 0.51 paid on Nov 27, 2023 going ex on Nov 10, 2023
Nov 13, 2023
Nov 27, 2023
Nov 10, 2023
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™